(S)-2-(1-((7H-purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one-D5; 5-Fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-4(3H)-quinazolinone-D5; CAL 101-D5; Delalisib-D5; GS 1101-D5; Idelalisib-D5; N6-[(S)-1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl]adenine-D5; Zydelig
Idelalisib-d5 is a fully characterized chemical compound used as a reference standard of API Idelalisib. The standard offered is compliant with regulatory guidelines. Idelalisib-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 870281-82-6 (non-d)
